Health-related quality-of-life results from PALETTE: A randomized, double-blind, phase 3 trial of pazopanib versus placebo in patients with soft tissue sarcoma whose disease has progressed during or after prior chemotherapy - A European Organization for research and treatment of cancer soft tissue and bone sarcoma group global network study (EORTC 62072)

Corneel Coens, Winette T A Van Der Graaf, Jean Yves Blay, Sant P. Chawla, Ian Judson, Roberta Sanfilippo, Stephanie C. Manson, Rachel A. Hodge, Sandrine Marreaud, Judith B. Prins, Iwona Lugowska, Saskia Litière, Andrew Bottomley

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Health-related quality-of-life results from PALETTE: A randomized, double-blind, phase 3 trial of pazopanib versus placebo in patients with soft tissue sarcoma whose disease has progressed during or after prior chemotherapy - A European Organization for research and treatment of cancer soft tissue and bone sarcoma group global network study (EORTC 62072)'. Together they form a unique fingerprint.

Medicine & Life Sciences